免疫功能低下儿童Brevundimonas感染:2例报告。

IF 1.7 Q3 INFECTIOUS DISEASES GERMS Pub Date : 2023-03-31 eCollection Date: 2023-03-01 DOI:10.18683/germs.2023.1369
Andreé Altamirano-Beltrán, Christian Chiara-Chilet, José W López, Maria J Pons, Julio Maquera-Afaray
{"title":"免疫功能低下儿童Brevundimonas感染:2例报告。","authors":"Andreé Altamirano-Beltrán, Christian Chiara-Chilet, José W López, Maria J Pons, Julio Maquera-Afaray","doi":"10.18683/germs.2023.1369","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong><i>Brevundimonas</i> spp. are rare and opportunistic pathogens which may cause infections in patients who are immunocompromised or have underlying disease.</p><p><strong>Case report: </strong>Two cases with a microbiological diagnosis of <i>Brevundimonas aurantiaca</i> and <i>Brevundimonas</i> spp. are presented. Both occurred in immunocompromised patients with post-chemotherapy febrile neutropenia for B-type acute lymphoblastic leukemia and hepatoblastoma. Antibiogram findings showed resistance to quinolones, ceftazidime, and intermediate resistance to cefepime, being susceptible to carbapenems and aminoglycosides. The cases responded favorably to the administration of carbapenem.</p><p><strong>Conclusions: </strong>The identification of the species and antimicrobial susceptibility profile favor response to infection, denoting the importance of species identification and the performance of an antibiogram to determine the different susceptibility profiles described in the literature on this emerging pathogen.</p>","PeriodicalId":45107,"journal":{"name":"GERMS","volume":"13 1","pages":"72-79"},"PeriodicalIF":1.7000,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659748/pdf/","citationCount":"0","resultStr":"{\"title\":\"<i>Brevundimonas</i> spp. infection in immunocompromised children: Two case reports.\",\"authors\":\"Andreé Altamirano-Beltrán, Christian Chiara-Chilet, José W López, Maria J Pons, Julio Maquera-Afaray\",\"doi\":\"10.18683/germs.2023.1369\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong><i>Brevundimonas</i> spp. are rare and opportunistic pathogens which may cause infections in patients who are immunocompromised or have underlying disease.</p><p><strong>Case report: </strong>Two cases with a microbiological diagnosis of <i>Brevundimonas aurantiaca</i> and <i>Brevundimonas</i> spp. are presented. Both occurred in immunocompromised patients with post-chemotherapy febrile neutropenia for B-type acute lymphoblastic leukemia and hepatoblastoma. Antibiogram findings showed resistance to quinolones, ceftazidime, and intermediate resistance to cefepime, being susceptible to carbapenems and aminoglycosides. The cases responded favorably to the administration of carbapenem.</p><p><strong>Conclusions: </strong>The identification of the species and antimicrobial susceptibility profile favor response to infection, denoting the importance of species identification and the performance of an antibiogram to determine the different susceptibility profiles described in the literature on this emerging pathogen.</p>\",\"PeriodicalId\":45107,\"journal\":{\"name\":\"GERMS\",\"volume\":\"13 1\",\"pages\":\"72-79\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2023-03-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659748/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"GERMS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18683/germs.2023.1369\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/3/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"GERMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18683/germs.2023.1369","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

Brevundimonas spp是罕见的机会性病原体,可引起免疫功能低下或有基础疾病的患者感染。病例报告:两个病例与微生物诊断的aurantiaca Brevundimonas和Brevundimonas属提出。这两种情况都发生在b型急性淋巴细胞白血病和肝母细胞瘤患者化疗后发热性中性粒细胞减少的免疫功能低下患者中。抗生素检查结果显示对喹诺酮类、头孢他啶耐药,对头孢吡肟中等耐药,对碳青霉烯类和氨基糖苷类敏感。这些病例对碳青霉烯的使用反应良好。结论:物种鉴定和抗菌药物敏感性谱有利于对感染的反应,表明物种鉴定和抗生素谱在确定文献中描述的这种新兴病原体的不同敏感性谱方面的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Brevundimonas spp. infection in immunocompromised children: Two case reports.

Introduction: Brevundimonas spp. are rare and opportunistic pathogens which may cause infections in patients who are immunocompromised or have underlying disease.

Case report: Two cases with a microbiological diagnosis of Brevundimonas aurantiaca and Brevundimonas spp. are presented. Both occurred in immunocompromised patients with post-chemotherapy febrile neutropenia for B-type acute lymphoblastic leukemia and hepatoblastoma. Antibiogram findings showed resistance to quinolones, ceftazidime, and intermediate resistance to cefepime, being susceptible to carbapenems and aminoglycosides. The cases responded favorably to the administration of carbapenem.

Conclusions: The identification of the species and antimicrobial susceptibility profile favor response to infection, denoting the importance of species identification and the performance of an antibiogram to determine the different susceptibility profiles described in the literature on this emerging pathogen.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
GERMS
GERMS INFECTIOUS DISEASES-
CiteScore
2.80
自引率
5.00%
发文量
36
期刊最新文献
Comparative phenotypic and proteomic analysis of colistin-exposed Pseudomonas aeruginosa. In vivo systemic vancomycin determination from polymethyl methacrylate and morselized bone allograft used in two stage septic knee revision arthroplasty. Investigation of risk factors for household-based dengue virus infection in Borobudur Subdistrict, Magelang, Indonesia. Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024". The first case of alveolar echinococcosis from southern Croatia: progressive course of the disease in an immunocompromised patient.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1